TITLE

Diabetes and 30-Day Mortality From Peptic Ulcer Bleeding and Perforation

AUTHOR(S)
Thomsen, Reimar W.; Riis, Anders; Christensen, Steffen; Nørgaard, Mette; Sørensen, Henrik T.
PUB. DATE
April 2006
SOURCE
Diabetes Care;Apr2006, Vol. 29 Issue 4, p805
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE -- Diabetes may influence the outcome of complicated peptic ulcer disease, due to angiopathy, blurring of symptoms, and increased risk of sepsis. We examined whether diabetes increased 30-day mortality among Danish patients hospitalized with bleeding or perforated peptic ulcers. RESEARCH DESIGN AND METHODS -- This population-based cohort study took place in the three Danish counties of North Jutland, Viborg, and Aarhus between 1991 and 2003. Patients hospitalized with a first-time diagnosis of peptic ulcer bleeding or perforation were identified using the counties' hospital discharge registries. Data on diabetes, other comorbidities, and use of ulcer-associated drugs were obtained from discharge registries and prescription databases. The Danish Civil Registry System allowed complete follow-up for mortality. The outcome under study was 30-day mortality in diabetic versus nondiabetic patients, adjusted for potential confounders. RESULTS -- We identified 7,232 patients hospitalized for bleeding ulcers, of whom 731 (10.1%) had diabetes. The 30-day mortality among diabetic patients was 16.6 vs. 10.1% for other patients with bleeding ulcers. The adjusted 30-day mortality rate ratio (MRR) for diabetic patients was 1.40 (95% CI 1.15-1.70). We also identified 2,061 patients with perforated ulcers, of whom 140 (6.8%) had diabetes. The 30-day mortality among diabetic patients was 42.9 vs. 24.0% in other patients with perforated ulcers, corresponding to an adjusted 30-day MRR of 1.51 (1.15-1.98). CONCLUSIONS -- Among patients with peptic ulcer bleeding and perforation, diabetes appears to be associated with substantially increased short-term mortality.
ACCESSION #
20443245

 

Related Articles

  • Editorial: Upper GI Bleeding–Associated Mortality: Challenges To Improving A Resistant Outcome. Lanas, Angel // American Journal of Gastroenterology;Jan2010, Vol. 105 Issue 1, p90 

    Although the incidence of peptic ulcer bleeding (PUB) has decreased, mortality has remained constant despite the advances in endoscopic and pharmacological therapies. Recent data indicate that most PUB-linked deaths are not direct sequelae of the bleeding ulcer itself. Instead, mortality derives...

  • Peptic Ulcer Bleeding: Comparison of Two Hemostatic Procedures. Buffoli, F.; Graffeo, M.; Nicosia, F.; Gentile, C.; Cesari, P.; Rolfi, F.; Paterlini, A. // American Journal of Gastroenterology;Jan2001, Vol. 96 Issue 1, p89 

    OBJECTIVE: Bleeding is a serious complication of peptic ulcer. Endoscopic injection therapy is accepted as a homeostatic endoscopic treatment in acute nonvariceal of upper GI hemorrhages, particularly in bleeding peptic ulcers. The risk of rebleeding is predicted by the endoscopic appearance of...

  • Treatment of nonvariceal upper gastrointestinal bleeding. Rivkin, Kirill; Lyakhovetskiy, Aleksandr // American Journal of Health-System Pharmacy;6/1/2005, Vol. 62 Issue 11, p1159 

    Purpose. The etiology, pathophysiology, prognostic factors, pharmacologic treatment, and pharmacoeconomic considerations of nonvariceal upper-gastrointestinal-tract bleeding (UGB) are reviewed. Summary. UGB is associated with substantial morbidity and mortality. While UGB can be caused by a wide...

  • SURGICAL MANAGEMENT OF ACUTE NON-VARICEAL GASTROINTESTINAL BLEEDING: A PRE-MORTAL EVENT. Williams, G. L.; Harvey, J. S.; Hebden, M.; Swift, G. L.; Green, J. T. // Gut;Apr2004 Supplement 3, Vol. 53, pA76 

    A small group of patients require urgent life saving surgery for upper gastrointestinal bleeding. Fewer surgeons are experienced in operating for peptic ulcer disease and the patients are usually elderly and at high surgical risk. The recent trend is to perform less radical and quicker surgery...

  • Management of haematemesis and melaena. Palmer, K. // Postgraduate Medical Journal;Jul2004, Vol. 80 Issue 945, p399 

    Acute upper gastrointestinol bleeding is a common medical emergency which carries hospital mortality in excess of 10%. The most important causes are peptic ulcer and varices. Varices are treated by endoscopic band ligation or injection sclerotherapy and management of the underlying liver...

  • CLINICAL EFFECTIVENESS OF IV OMEPRAZOLE IN ENDOSCOPICALLY TREATED PEPTIC ULCER DISEASE. Praveen, E.; Caims, A.; Ali, F.; Duane, P. D. // Gut;Apr2004 Supplement 3, Vol. 53, pA76 

    Recent RCT data have demonstrated significant benefits of a 72 hour IV omeprazole infusion, for patients undergoing endoscopic haemostasis for bleeding peptic ulcers. This article presents a study to assess the effectiveness of IV omeprazole on outcomes, a retrospective audit of all patients...

  • Giant Prepyloric Ulcer Haemorrhage: Patient Characteristics, Treatment, and Outcome in 2003-2012. Peetsalu, Margot; Kirsimägi, Ülle; Peetsalu, Ants // Ulcers;2014, p1 

    The aim of the study was to characterize patients with giant prepyloric ulcer haemorrhage, their treatment, and outcome. The data for 929 peptic ulcer haemorrhage (PUH) patients were divided into three groups according to ulcer location: group I: 165 prepyloric ulcer patients, group II: 353...

  • Combination Treatment for Peptic Ulcers at High Risk for Recurrent Bleeding. Sung, J.J.Y.; Chan, F.K.L.; Lau, J.Y.W.; Yung, M.-Y.; Leung, W.-K.; Wu, J.C.Y.; Ng, E.K.W.; Chung, S.C.S. // Annals of Internal Medicine;8/19/2003, Vol. 139 Issue 4, pI12 

    Focuses on combination treatment for peptic ulcers at high risk for recurrent bleeding. Definition of peptic ulcers; Form of treatment that stop active bleeding and prevent recurrent bleeding; Drugs involved in endoscopic treatment of blood vessel.

  • Stopping the haemorrhage from peptic ulcers. Young, A.E. // British Medical Journal (Clinical Research Edition);2/20/1982, Vol. 284 Issue 6315, p530 

    Examines the haemorrhage from peptic ulcers. Treatment of the blood loss; Impact of somatostatin on gastrin release; Reduction of the blood flow in the coeliac axis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics